Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
17.60
+0.64 (3.77%)
Nov 1, 2024, 4:00 PM EDT - Market closed

Cadrenal Therapeutics Market Cap

Cadrenal Therapeutics has a market cap or net worth of $26.34 million as of November 1, 2024. Its market cap has increased by 242.12% in one year.

Market Cap
26.34M
Enterprise Value
21.31M
1-Year Change
242.12%
Ranking
Category
Stock Price
$17.60

Market Cap Chart

Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $26.34M, a decrease of -54.72%. That is a compound annual growth rate of -35.86%.

History

DateMarket Cap% Change
Nov 1, 202418.80M95.83%
Dec 29, 20239.60M-83.50%
Jan 20, 202358.17M-
View and export this data all the way back to 2023. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Spectral AI 27.21M
OneMedNet 27.05M
Bionano Genomics 27.03M
CytoMed Therapeutics 26.60M
Pluri 26.53M
Lisata Therapeutics 26.29M
Estrella Immunopharma 26.27M
BioXcel Therapeutics 26.20M
Market Cap Rankings